Concepedia

Accelerating Pediatric Cancer Drug Development: Challenges and Opportunities for Pediatric Master Protocols

Tahira Khan, Mark Stewart, Samuel C. Blackman, Raphaël F. Rousseau, Martha Donoghue, Kenneth J. Cohen, Nita L. Seibel, Mark E. Fleury, Bouchra Benettaib, Raleigh Malik,

Therapeutic Innovation & Regulatory Science · 2018 · 48 citations · 10 references

DOI

Concepts

References

10

Cancer statistics, 2017

Rebecca L. Siegel, Kimberly D. Miller, Ahmedin Jemal · CA A Cancer Journal for Clinicians · 2017 · 15K citations · Full text

, , +16

Mutational heterogeneity in cancer and the search for new cancer-associated genes

Michael S. Lawrence, Petar Stojanov, Paz Polak et al. · Nature · 2013 · 5.7K citations · Full text

, , +14

Optimal two-stage designs for phase II clinical trials

Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations

, , +10

K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas

Dong-Anh Khuong-Quang, Pawel Buczkowicz, Patricia Rakopoulos et al. · Acta Neuropathologica · 2012 · 1K citations · Full text

, , +17

Master Protocols to Study Multiple Therapies, Multiple Diseases, or Both

Janet Woodcock, Lisa M. LaVange · New England Journal of Medicine · 2017 · 1K citations · Full text

, , +9